Related Experiment Video
Updated: Jan 28, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Modeling Pancreatic Cancer Dynamics with Immunotherapy.
Xiaochuan Hu1,2, Guoyi Ke1,3, Sophia R-J Jang4
1Department of Mathematics and Statistics, Texas Tech University, Lubbock, TX, 79409-1042, USA.
Mathematical modeling reveals that combining immunotherapies is crucial for pancreatic cancer survival. Sequential treatment, starting with TGF-β inhibition followed by immune cell transfers, shows promising results.
Area of Science:
- Computational biology and mathematical modeling of cancer immunology.
- Translational research in oncology and immunotherapy development.
Background:
- Pancreatic cancer poses a significant challenge due to its complex tumor microenvironment.
- Current immunotherapies often show limited efficacy as monotherapies for pancreatic cancer.
Purpose of the Study:
- To develop and validate a mathematical model simulating pancreatic cancer dynamics.
- To investigate the efficacy of various immunotherapy strategies, including combined approaches.
- To explore optimal scheduling for combined immunotherapies to improve patient survival.
Main Methods:
- Development of a mathematical model incorporating cancer cells, immune cells, and cytokines.
- Model validation using clinical trial survival data.
- Sensitivity analysis and optimal control theory application for immunotherapy optimization.
- Numerical simulations of combined immunotherapies (adoptive cell transfer and TGF-β inhibition).
Main Results:
- The model identified a critical threshold for pro-tumor cytokine activation for cancer eradication.
- Combined immunotherapy, specifically anti-transforming growth factor-beta (TGF-β) and adoptive immune cell transfer, significantly prolongs survival.
- Therapeutic scheduling is critical; initiating TGF-β inhibition before immune cell transfer yields superior outcomes.
Conclusions:
- Monotherapy is insufficient for controlling pancreatic cancer.
- Combined immunotherapy strategies, particularly sequential TGF-β inhibition and adoptive cell transfer, offer a promising approach to enhance patient survival.
- Mathematical modeling provides valuable insights for optimizing cancer immunotherapy protocols.
Related Concept Videos
Tumor Immunotherapy
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Dynamic Equilibrium
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

